Salarius Pharmaceuticals, Inc. (SLRX)
0.6693
+0.02
(+3.16%)
USD |
NASDAQ |
Jan 02, 16:00
0.5151
-0.15
(-23.04%)
After-Hours: 17:51
Salarius Pharmaceuticals Research and Development Expense (TTM): 0.4291M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| CorMedix, Inc. | 12.46M |
| Outset Medical, Inc. | 23.19M |
| Vor Biopharma, Inc. | 327.69M |
| Humacyte, Inc. | 75.35M |